ArticleAnnals of hematology2026

Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphoma.

Qing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.